For decades, biopharmaceutical companies have trusted us to deliver high performing, high quality, cell culture media (CCM) for a diverse range of biologics. Whether you need to intensify a CHO-based process or optimize production of vaccines or novel modalities such as cell and gene therapies, our cell culture media will help make your processes more robust and efficient.
Webinar: Turnkey Solutions for Upstream Cell Culture Processes
Webinar: Media and Process Development for Seed Train Intensification
Webinar: A Cost Analysis and Evaluation of Perfused Seed Train Scenarios Through Process Modeling
Flyer: Minimizing the Presence of Bioburden - Strategies to Protect Dry Powder Media
Flyer: CHO Cell Culture Media and Feeds
Technical Note: Stemline® XF MSC Medium has High Yield and Functionality in the 3 L Mobius® Stirred Tank Bioreactor
App Note: Optimizing Feed Strategies with Cellvento® ModiFeed Prime COMP: A Scalable Process
White paper: Improving fed-batch Yields by Combining EX-CELL® Advanced and Cellvento® Cell culture Media Portfolios
White Paper: Seed Train Intensification
White Paper: Accelerating Cell Line and Process Development
White Paper: Strategies for Upstream Intensification
White Paper: Optimizing Media Feeding Strategies Guidance for Cellvento® CHO Media Platform (1st GEN)
White Paper: Use of a Chemically Defined Cloning Medium for Quality and Regulatory Risk Mitigation in Cell Line Development
Brochure: Cell Culture Media Supply Robustness and Control
We offer a broad portfolio of industry-proven CHO media for the seed train (N-1), perfusion, fed-batch, and cell line development. These purpose-built formulations are designed to contain only those raw materials that have a specific role in supporting cell vitality and productivity. As problem solvers we also identify opportunities to further improve media consistency and handling, such as modified amino acids, a novel poloxamer, auto pH, and compaction to match novel process designs.
The result? Media that are tailored for your specific CHO-based application, maximizing productivity and enabling upstream process intensification – while keeping pace with evolving regulatory requirements.
For fed-batch processes, we aim to reduce the complexity of workflows by offering highly concentrated, one-part pH neutral feeds, allowing for a reduction in volume of feed added to replenish depleted nutrients, thereby increasing product yield. Highly concentrated, compacted format, easy to hydrate and product stability even at room temperature allow for streamlined workflows.
The production of vaccines and novel modalities such as cell and gene therapies require specialized media that deliver high performance and high quality. In addition to offering customized products, our portfolio includes media for manufacturing virus-like particles for vaccines and viral vectors such as AAV and lentiviruses for use in cell and gene therapies.
With complex manufacturing processes and proximity of the cell culture medium to the patient, formulations for cell therapy production must meet stringent and unique requirements for performance and quality. Our media products for cell therapy and viral vector production incorporate carefully selected raw materials and supplements that optimize cell expansion performance and ensure regulatory compliance in cell and gene therapy manufacturing environments.